Analyst Ratings for Ironwood Pharmaceuticals (IRWD) [Sells]

IRWD Rating Summary

IRWD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on IRWD
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $14.90 (+40.6%) * Over Last 12-Mos
Rating Score: 3.8 / 10
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
9/17/2013 Goldman Sachs New Coverage Sell
(N/A)
9.50
(N/A)
13.64 10.60 -22.29% Details
1/16/2013 UBS Downgrade Sell
(Neutral)
N/A
(N/A)
14.69 10.60 -27.84% Details
Like IRWD Ratings? Also take a look at SGYP, EXAS, ACT, ICPT

IRWD Ratings News